Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients

J E Bell, Y K Donaldson, S Lowrie, C A McKenzie, R A Elton, A Chiswick, R P Brettle, J W Ironside, P Simmonds

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To determine the associations between HIV encephalitis and other central nervous system (CNS) pathology, viral burden, cognitive impairment, zidovudine therapy and risk group in AIDS patients.
Original languageEnglish
Pages (from-to)493-9
Number of pages7
JournalAIDS
Volume10
Issue number5
Publication statusPublished - May 1996

Keywords

  • AIDS Dementia Complex
  • AIDS-Related Opportunistic Infections
  • Acquired Immunodeficiency Syndrome
  • Adult
  • Antiviral Agents
  • Cognition
  • Cohort Studies
  • DNA, Viral
  • Encephalitis, Viral
  • Female
  • Frontal Lobe
  • Great Britain
  • HIV Core Protein p24
  • HIV-1
  • Homosexuality, Male
  • Humans
  • Immunocompromised Host
  • Lymphoma, AIDS-Related
  • Male
  • Risk Factors
  • Substance Abuse, Intravenous
  • Zidovudine

Fingerprint

Dive into the research topics of 'Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients'. Together they form a unique fingerprint.

Cite this